2-Hydroxy-5-methylpyridine - Names and IdentifiersName2-Hydroxy-5-methylpyridineSynonymsAKOS BB
Courriel : info@standard-groups.com
Nom | 2-Hydroxy-5-methylpyridine |
Synonymes | AKOS BBS-00002970 5-Methyl-2-pyridinol 6-HYDROXY-3-PICOLINE 5-METHYL-2-PYRIDINOL 5-METHYL-PYRIDIN-2-OL 2-Pyridinol,5-methyl- 5-METHYLPYRIDINE-2-ONE 5-METHYL-2(1H)PYRIDONE 5-methyl-(1H)pyridinone 5-Methyl 2-(1H)pyridinone 5-methylpyridin-2(1H)-one 5-Methyl-2(1H)pypridinone 5-METHYL-2(1H)-PYRIDINONE 5-METHYL-2(1H)PYPRIDINONE 4-methylpyridin-2(1H)-one 5-Methyl-2-(1H)pyridinone 2-Hydroxy-5-methylpyridine 5-Methyl-2-hydroxypyridine |
CAS | 1003-68-5 91914-06-6 |
EINECS | 213-713-9 |
InChI | InChI=1/C6H7NO/c1-5-2-3-7-6(8)4-5/h2-4H,1H3,(H,7,8) |
Inchikey | SOHMZGMHXUQHGE-UHFFFAOYSA-N |
Formule moléculaire | C6H7NO |
Masse molaire | 109.13 |
Densité | 1.053±0.06 g/cm3(Predicted) |
Point de fusion | 183-187 °C (lit.) |
point Boling | 304.2±15.0 °C(Predicted) |
Point d'éclair | 170.6 °C |
Solubilité | DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) |
pression vapeur | 0 mmHg à 25°C |
Apparence | White to brown powder or crystal |
Couleur | Pale Yellow to Light Yellow |
BRN | 107074 |
Le PKA | 12.43±0.10(Predicted) |
Condition de stockage | Scellé à sec, température ambiante |
Indice de réfraction | 1.551 |
MDL | MFCD03092888 |
Propriétés physiques et chimiques |
Symboles de danger | XN - nocif |
Codes de risque | R22 - nocif si avalé R37 / 38 - irritation du système respiratoire et de la peau. R41 - Risque de dommages graves aux yeux R36/37/39 - |
Description de la sécurité | S26 - En cas de contact avec les yeux, rincer immédiatement avec beaucoup d'eau et consulter un médecin. S36 - porter des vêtements de protection appropriés. S37 - Wear suitable gloves. |
Wgk Allemagne | 3 |
Code SH | 29333990 |
Informations chimiques NIST | Informations fournies par : webbook.nist.gov (lien externe) |
Application | 2-hydroxy-5-methylpyridine is a pharmaceutical intermediate that can be used to prepare pirfenidone. Pirfenidone is a new pyridone compound with broad-spectrum anti-fibrosis effect, which is a white or light yellow crystalline powder. It can prevent and reverse the formation of fibrosis and scars; and the drug also has a good effect in renal interstitial fibrosis, liver fibrosis and other fibrotic diseases; at the same time, it is also used in kidney disease (focal segmental glomerulosclerosis), Hypertrophic cardiomyopathy, adult type I multiple neurofibroma, adolescent type I multiple neurofibroma and plexiform neurofibroma, diabetes with kidney disease, uterine leiomyoma and other phase II clinical studies have a wide range of applications. |
Préparation | (1) mix 2-amino -5-methylpyridine, diazotization reagent and water evenly, cool to -4 ℃-3 ℃, add acidic solution for heat preservation reaction; After the reaction is complete, heat hydrolysis and cooling, and then adjust the pH to 6.5-7.5 with a mass fraction of 30% sodium hydroxide solution, the organic phase is extracted by the first solvent, dried and concentrated under reduced pressure to obtain 2-hydroxy-5-methylpyridine crude product;(2) A second solvent is added to the 2-hydroxy-5-methylpyridine crude product, heated and refluxed, cooled and crystallizated, pumped and dried to produce 2-hydroxy-5-methylpyridine pure product. |
Disclaimer: Le contenu ci-dessus est destiné à des fins de référence et de communication uniquement entre les initiés de l'industrie, et ne garantit pas son exactitude ou son exhaustivité. Conformément aux lois et règlements pertinents et aux règlements de ce site Web, les unités ou personnes qui achètent des articles connexes doivent obtenir des qualifications et des conditions de qualification valides.
Téléphone de l'entreprise
+86-21-6420 0566
Heures de travail
Du lundi au vendredi
Téléphone portable:
13816217984
Courriel :
info@qinsun-lab.com